Implantable drug shows promise for obesity in early trial
NCT ID NCT05670379
First seen Nov 01, 2025 · Last updated Jun 02, 2026 · Updated 35 times
Summary
This early-stage study tested a small implant that releases exenatide, a drug used for weight control, in 24 overweight or obese adults without diabetes. The goal was to check safety and how the drug behaves in the body. Participants received the implant under the skin and were monitored for side effects and drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMax
Adelaide, Australia
Conditions
Explore the condition pages connected to this study.